Skip to main content
. 2024 Jun 4;19(6):e0304766. doi: 10.1371/journal.pone.0304766

Table 1. Main sociodemographic and clinical characteristics of the study population.

Main characteristics Controls (n = 104) Cases (n = 117) p value
Age (years) 37.00 [6.00] 43.00 [9.00] < 0.001
BMI* (kg/m 2 ) 23.72 [5.58] 23.80 [5.76] 0.234
    Underweight (<18,5) 4 (3.85) 5 (4.27) NA
    Normal weight (18,5–24,9) 61 (58.65) 62 (52.99) NA
    Overweight(25–29,9) 29 (27.88) 29 (24.79) NA
    Obesity (>30) 10 (9.62) 21 (17.95) NA
Pathology      
    No hormone-dependent pathology 104 (100.00) -  
    Leiomyomas - 74 (63.25)  
    Endometriosis - 21 (17.95)  
    Leiomyomas and endometriosis - 22 (18.80)  
Hormonal contraception (HC)      
    Ever users of HC 60 (57.69) 62 (53.45) 0.527
    Oral contraceptives 51 (49.04) 57 (50.00) 0.887
    Transdermal patch 4 (3.85) 3 (2.63) 0.712
    Vaginal ring 13 (12.50) 6 (5.26) 0.058
    LNG releasing IUD 3 (2.88) 10 (8.77) 0.067
    Contraceptive implant 2 (1.92) 2 (1.75) 1.000
Time of HC use (years) 6.00 [7.00] 5.00 [7.75] 0,737
Parity      
    Number of children 2 [1.00] 1 [2.00] < 0,001
    Nuliparous 3 (2.88) 51 (43.97) < 0,001
    Age at first childbirth (years) 33.00 [6.00] 30.0 [9.00] 0,004
Postmenopausal 2 (1.92) 6 (5.17) 0,286
Current smokers      
    Yes 5 (4.81) 18 (15.52) 0,010
    Years of smoking habit 10.80 [10.03] 22.50 [9.91] 0,043
    Number of cigarretes/day 10.00 [9.00] 10.00 [9.75] 0,880
No      
    Former smokers 47 (45.19) 41 (35.34) 0,137
    Years since termination 3.00 [7.00] 9.50 [11.75] <0,001
Never smokers 52 (50.00) 57 (49.14) 0,898